Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 9.66 |
| Open | 9.74 |
| Bid | 9.53 x 200 |
| Ask | 9.61 x 200 |
| Day's Range | 9.38 - 9.76 |
| 52 Week Range | 9.02 - 14.57 |
| Volume | |
| Avg. Volume | 2,864,904 |
| Market Cap | 2.838B |
| Beta (5Y Monthly) | 0.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.49 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.33 |
ZacksDo Options Traders Know Something About Amicus (FOLD) Stock We Don't?
Investors need to pay close attention to Amicus (FOLD) stock based on the movements in the options market lately.
Insider MonkeyAmicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript May 9, 2024 Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15985 EPS, expectations were $-0.06. Amicus Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning […]
- GuruFocus.com
Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...
Comprehensive Analysis of Amicus Therapeutics' First Quarter Financial Performance
© 2024 Yahoo. All rights reserved.